Notably, insights from cancer biology, where both immune and metabolic networks are commonly dysregulated, have identified two key regulators: Raf kinase inhibitor protein (RKIP) and its counter-regulator Yin Yang 1 (YY1). Here, YY1 is linked to cancer.